About Us

H.I.G. BioHealth Partners invests in a broad range of biohealth opportunities across sectors and stages. Our seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. We invest in companies developing novel products for significant unmet medical needs, primarily in the following sectors:

  • Therapeutics (small molecules, protein therapeutics, antibodies, etc.)
  • Medical devices
  • Diagnostics

After making an investment, the H.I.G. BioHealth Partners team works closely with portfolio companies in key areas, including:

  • Pre-clinical and clinical development strategy
  • Management recruitment
  • Business development activities
  • Follow on equity and debt financing
  • Achieving liquidity through M&A or IPO